Search Menu
Photonics Media Photonics Marketplace Photonics Spectra BioPhotonics Vision Spectra Photonics Showcase Photonics ProdSpec Photonics Handbook

Funding Furthers OnTarget Imaging Research

Facebook Twitter LinkedIn Email
WEST LAFAYETTE, Ind., March 12, 2014 — Further development of optical imaging technology for cancer research is now possible, thanks to $15 million in funding recently awarded to OnTarget Labs.

Based at the Purdue University Research Park, OnTarget received the funding from the Pension Fund of the Christian Church and from Tom Hurvis, original investor in the company and founder of Old World Industries.

The technology and research was developed by Philip Low, a chemistry professor and director of the Center for Drug Discovery at Purdue University, and co-founder of OnTarget. It is based on the over-expression of specific receptors on solid cancers.

The funding will also enable further clinical trials necessary for optimizing the technology platform.

For more information, visit:
Mar 2014
AmericasBiophotonicsBusinesscancerclinical trialsimagingIndianaoptical imaging technologyopticsPurdue UniversityResearch & TechnologyOnTarget LaboratoriesPurdue University Research ParkOld World IndustriesPension Fund of the Christian ChurchCenter for Drug Discovery

back to top
Facebook Twitter Instagram LinkedIn YouTube RSS
©2023 Photonics Media, 100 West St., Pittsfield, MA, 01201 USA, [email protected]

Photonics Media, Laurin Publishing
x We deliver – right to your inbox. Subscribe FREE to our newsletters.
We use cookies to improve user experience and analyze our website traffic as stated in our Privacy Policy. By using this website, you agree to the use of cookies unless you have disabled them.